The COVID-19 Pandemic – News and Features

Fundamental research supported by supercomputers could help lead to new strategies and better technology that combats infectious and genetic diseases.

Experts from the Seattle Cancer Care Alliance are sharing insights on how to continue providing optimal cancer care during the novel coronavirus (COVID-19) pandemic.

As the coronavirus spreads around the world, CBD misinformation has followed.

In this article, we review two key questions that remain around the spread of the novel coronavirus SARS-CoV-2.

The COVID-19 outbreak caused by the spread of the virus SARS-CoV-2 is a product of natural evolution, scientists conclude in a correspondence piece published in Nature Medicine .

Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency and Health Research Authority to conduct a trial of SNG001 in COVID-19 patients to potentially help with the global outbreak of the virus.

Researchers have detected COVID-19 viral RNA and live virus in specimens other than nose-throat swabs and sputum samples, raising the possibility that the disease may spread through additional routes and thus testing should be changed accordingly.

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, suggesting that people may acquire the virus through the air and after touching contaminated objects.

It has been estimated that 60% of the population would need to be infected for herd immunity to be achieved, clearly leading to many deaths. But what is herd immunity and could it realistically be a viable option in tackling the current coronavirus pandemic?

A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle.